The initiative, promoted by the Escolab program and carried out by IDIBELL, has been carried out with 4th year ESO students from the Escola Pia of Granollers.
An international consortium led by IRB Barcelona and the biotech company Merus, with the participation of IDIBELL and the Catalan Institute of Oncology, presents the preclinical data leading to the discovery of MCLA-158 and its action mechanism on cancer stem cells.
Two of the 2021 Biologist Day awards, celebrated by the College of Biologists of Catalonia, are given to two members of IDIBELL: Dr. Milagros González Garrigues and Dr. Núria Sala-Serra.
Two IDIBELL members receive 2021 Biologist Day awards Read More »
On Thursday afternoon, April 21, the Presentation Conference of the Bellvitge Campus Scientific and Technical Services for Clinical Research took place with the aim of raising awareness of the research support services that IDIBELL and UB offer to researchers in the Bellvitge Campus.
Researchers from IDIBELL, HUB, UAB and Hospital del Mar have identified the presence of an ALS biomarker outside the nucleus of skin cells of patients. The discovery can be very useful for cases in which diagnosis is difficult, or in those with a family history of ALS, and even for early diagnosis.
Study of skin biopsies offers potential as new diagnostic marker for ALS Read More »
IDIBELL, together with other scientific institutions in Catalonia, is already part of the Scientific Committee for Pessics de Ciència.
IDIBELL becomes a member of the Pessics de Ciència Scientific Committee Read More »
The second edition of the RECERCLIPS collection explains genetics research at IDIBELL and is presented by the youtuber Juliana Canet.
The glass ceiling, family reconciliation and gender stereotypes are barriers that have had to be overcome, but they have not been an impediment to becoming the leading scientists today.
Research is written in feminine: IDIBELL women and their career Read More »
A study by IDIBELL and ICO, published in the journal Nature Communications, indicates that overexpression of the HMMR gene in women with BRCA1 mutations alters key cellular processes and accelerates the development of breast cancer.
An international team led by IDIBELL and Necker Hospital in Paris has identified mutations in the SLC35B2 gene as responsible for a syndrome that, although very rare and hitherto unknown, could be affecting hundreds of people around the world who would still remain undiagnosed. Symptoms of this disorder include neurodevelopmental delay, motor dysfunctions, and deformity
Researchers identify a gene that causes a new neurological and bone syndrome Read More »
